296 related articles for article (PubMed ID: 16325707)
1. Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy.
Ober MD; Yannuzzi LA; Do DV; Spaide RF; Bressler NM; Jampol LM; Angelilli A; Eandi CM; Lyon AT
Ophthalmology; 2005 Dec; 112(12):2088-94. PubMed ID: 16325707
[TBL] [Abstract][Full Text] [Related]
2. The natural history of pigment epithelial detachment associated with central serous chorioretinopathy.
Mudvari SS; Goff MJ; Fu AD; McDonald HR; Johnson RN; Ai E; Jumper JM
Retina; 2007; 27(9):1168-73. PubMed ID: 18046220
[TBL] [Abstract][Full Text] [Related]
3. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.
Chan WM; Lai TY; Lai RY; Liu DT; Lam DS
Ophthalmology; 2008 Oct; 115(10):1756-65. PubMed ID: 18538401
[TBL] [Abstract][Full Text] [Related]
4. Ocular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic central serous chorioretinopathy.
Canakis C; Livir-Rallatos C; Panayiotis Z; Livir-Rallatos G; Persidis E; Conway MD; Peyman GA
Am J Ophthalmol; 2003 Oct; 136(4):750-2. PubMed ID: 14516825
[TBL] [Abstract][Full Text] [Related]
5. Chronic central serous chorioretinopathy: photodynamic therapy.
Taban M; Boyer DS; Thomas EL; Taban M
Am J Ophthalmol; 2004 Jun; 137(6):1073-80. PubMed ID: 15183792
[TBL] [Abstract][Full Text] [Related]
6. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study.
Chan WM; Lai TY; Lai RY; Tang EW; Liu DT; Lam DS
Retina; 2008 Jan; 28(1):85-93. PubMed ID: 18185143
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy in chronic central serous chorioretinopathy.
Battaglia Parodi M; Da Pozzo S; Ravalico G
Retina; 2003 Apr; 23(2):235-7. PubMed ID: 12707605
[No Abstract] [Full Text] [Related]
8. Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography.
Fujimoto H; Gomi F; Wakabayashi T; Sawa M; Tsujikawa M; Tano Y
Ophthalmology; 2008 Sep; 115(9):1494-500, 1500.e1-2. PubMed ID: 18394706
[TBL] [Abstract][Full Text] [Related]
9. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study.
Yannuzzi LA; Slakter JS; Gross NE; Spaide RF; Costa D; Huang SJ; Klancnik JM; Aizman A
Retina; 2003 Jun; 23(3):288-98. PubMed ID: 12824827
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH
Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.
Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy for chronic central serous chorioretinopathy.
Cardillo Piccolino F; Eandi CM; Ventre L; Rigault de la Longrais RC; Grignolo FM
Retina; 2003 Dec; 23(6):752-63. PubMed ID: 14707823
[TBL] [Abstract][Full Text] [Related]
13. Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy.
Lim JI; Glassman AR; Aiello LP; Chakravarthy U; Flaxel CJ; Spaide RF;
Ophthalmology; 2014 May; 121(5):1073-8. PubMed ID: 24439758
[TBL] [Abstract][Full Text] [Related]
14. Visual outcome after discontinuation of corticosteroids in atypical severe central serous chorioretinopathy.
Sharma T; Shah N; Rao M; Gopal L; Shanmugam MP; Gopalakrishnan M; Bhende P; Bhende M; Shetty NS; Baluswamy S
Ophthalmology; 2004 Sep; 111(9):1708-14. PubMed ID: 15350327
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy.
Ergun E; Tittl M; Stur M
Arch Ophthalmol; 2004 Jan; 122(1):37-41. PubMed ID: 14718292
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors related to photodynamic therapy for central serous chorioretinopathy.
Moon JW; Yu HG; Kim TW; Kim HC; Chung H
Graefes Arch Clin Exp Ophthalmol; 2009 Oct; 247(10):1315-23. PubMed ID: 19421764
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy with Verteporfin for vascular leakage from a combined hamartoma of the retina and retinal pigment epithelium.
Cilliers H; Harper CA
Clin Exp Ophthalmol; 2006 Mar; 34(2):186-8. PubMed ID: 16626442
[TBL] [Abstract][Full Text] [Related]
18. Fluorescein angiography-guided photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy.
Koytak A; Erol K; Coskun E; Asik N; Öztürk H; Özertürk Y
Retina; 2010; 30(10):1698-703. PubMed ID: 20539254
[TBL] [Abstract][Full Text] [Related]
19. Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy.
Pryds A; Larsen M
Acta Ophthalmol; 2012 Dec; 90(8):738-43. PubMed ID: 21586096
[TBL] [Abstract][Full Text] [Related]
20. [Relation between retinal pigment epithelial detachment and dye leakage in central serous retinopathy].
Constantinides G
J Fr Ophtalmol; 2000 Sep; 23(7):649-54. PubMed ID: 10992059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
